Changes in etanercept and adalimumab biosimilar prescriptions for the initial treatment of rheumatoid arthritis in France: Data from the ART-SFR Registry.

Adeline Ruyssen-Witrand,Yacine Boudali,Isabelle Pane,Alain Cantagrel,Pascale Thevenot,Martin Soubrier,Jacques Morel,Eric Houvenagel,Alain Saraux, André Basch,Marie-Elise Truchetet,Hubert Marotte,Emmanuelle Dernis,Pascal Claudepierre,René-Marc Flipo,Jacques-Eric Gottenberg,Philippe Ravaud,Xavier Mariette,Raphaele Seror

Joint bone spine（2021）

引用 2|浏览7

暂无评分

摘要

•Disparities are observed in anti-TNF biosimilar prescriptions across countries.•In the French ART-SFR registry, anti-TNF biosimilar were prescribed in>90% of RA.•Important geographic/centre disparities in biosimilar prescriptions were observed.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要